Skip to main content
Caplight Logo









Ostia Sciences Inc.

Ostia Sciences Inc.

Private
TorontoHealthcare & Life Scienceshttps://ostiasciences.ca/

Last Round

Seed

Jul 18, 2025

Total Funding Raised

$1.73M

Momentum

Top 25%

of companies Caplight tracks

Company Overview

Ostia Sciences Inc. is a biotechnology company that develops innovative oral probiotics and biotherapeutics for improving global health outcomes.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Clinical Trials

Business Model

B2B

Customer Profile

Government Contracts, Revenue Share

AI Layer

Non-AI

Keywords

microbiome therapeuticsprobioticsoral microbiomebiotherapeuticslantibioticdrug discoverybugs to drugsimmunomodulationlive biotherapeuticsoral healthdrug discovery platformrespiratory healthclinical trialsCDMO partnership

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Ostia Sciences Inc. Comparables

Compare Ostia Sciences Inc. with similar companies based on industry and business-model similarity.

Ostia Sciences Inc. comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
DermBiont
80%
SciBac, Inc.
75%
Alveolus Bio
65%

Ostia Sciences Inc. Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedJul 18, 2025
GrantDec 31, 2024

Key People

Founding team and executive leadership

Michael Glogauer

Co-Founder and Chief Scientific Officer

Founding Team

Abdelahhad Barbour

CEO Co-Founder

Founding Team

Ostia Sciences Inc. Investors

Notable investors and investment history

Ostia Sciences Inc. investors
InvestorRounds
Natural Products CanadaSeed, Grant

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 26, 2026

    Monthly visitors increased 124% MoM.

  • Apr 20, 2026

    Received hands-on support from Invest Ontario for provincial expansion.

Ostia Sciences Inc. Filings

Explore SEC and related filing metadata, where available.

Ostia Sciences Inc. filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Ostia Sciences Inc.'s valuation, stock price, and market status.

Is Ostia Sciences Inc. a public or private company?

Ostia Sciences Inc. is a private company.

What is the current stock price of Ostia Sciences Inc.?

Ostia Sciences Inc. is a private company with no public stock price. No recent secondary market data is available.

How much is Ostia Sciences Inc. worth (valuation)?

Valuation information for Ostia Sciences Inc. is not publicly available.

Can I buy Ostia Sciences Inc. stock?

Ostia Sciences Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Ostia Sciences Inc.'s last funding round?

Ostia Sciences Inc.'s most recent funding round was Seed on July 18, 2025.

Who are the main investors in Ostia Sciences Inc.?

Key investors in Ostia Sciences Inc. include Natural Products Canada.

Will Ostia Sciences Inc. IPO soon?

No public IPO plans have been announced for Ostia Sciences Inc..

How can I track Ostia Sciences Inc. secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Ostia Sciences Inc.'s secondary market activity and sign up for updates.

Firmographic Details

HeadquartersToronto
Employee Range12
Year Founded2024
Last FundingJul 18, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?